Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

331
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
331
Modeling in Therapy01:26

Modeling in Therapy

606
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
606
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

864
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
864
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

835
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
835
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

642
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
642
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

559
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
559

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social Media Usage and Its Association With the Social Media Addiction Questionnaire Scale Among Early Adolescents.

JAACAP open·2026
Same author

Foetal Reduction in a Cornual Heterotopic Pregnancy With Potassium Chloride Administration.

Cureus·2026
Same author

Editors' Best of 2025.

JAACAP open·2026
Same author

Right Middle Cerebral Artery Occlusion Following Ovarian Hyperstimulation Syndrome: A Case Study.

Cureus·2026
Same author

Examining measurement discrepancies in adolescent screen media activity with insights from the ABCD study.

Npj mental health research·2025
Same author

Editors' Best of 2024.

JAACAP open·2025

Related Experiment Video

Updated: Feb 28, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.1K

Weeding Out the Justification for Marijuana Treatment in Patients with Developmental and Behavioral Conditions.

Theodora Nelson1, Yi Hui Liu, Kara S Bagot

  • 1*Division of General Academic Pediatrics and Child Development, University of California San Diego, Rady Children's Hospital, San Diego, CA; †Department of Psychiatry, University of California San Diego, Rady Children's Hospital, San Diego, CA.

Journal of Developmental and Behavioral Pediatrics : JDBP
|June 17, 2017
PubMed
Summary

This case series explores the use of medical marijuana in adolescents and adults with autism spectrum disorder (ASD) and co-occurring conditions. It highlights patient-reported benefits and concerns regarding cannabis for managing anxiety and challenging behaviors in ASD.

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

766
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

593

Related Experiment Videos

Last Updated: Feb 28, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.1K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

766
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

593

Area of Science:

  • Neurodevelopmental Disorders
  • Psychopharmacology
  • Cannabinoid Therapeutics

Background:

  • Autism spectrum disorder (ASD) is a complex neurodevelopmental condition often accompanied by significant behavioral and emotional challenges.
  • Co-occurring conditions such as anxiety, attention-deficit/hyperactivity disorder (ADHD), and mood disorders are prevalent in individuals with ASD.
  • Current treatment paradigms for ASD-related comorbidities often involve a combination of behavioral therapies and psychotropic medications, with varying degrees of success.

Observation:

  • The abstract presents three distinct cases: Alex, a 13-year-old with ASD, ADHD, anxiety, and depression, using marijuana for anxiety relief; Kevin, a 24-year-old with ASD, intellectual disability, and schizoaffective disorder, trialing medical marijuana for challenging behaviors; and Linda, an 11-year-old with ASD and anxiety, whose mother inquires about medical marijuana.
  • Alex reports using marijuana to self-medicate anxiety, questioning its problematic nature due to state legalization.
  • Kevin's father hopes medical marijuana will reduce his son's extensive psychotropic medication regimen.
  • Linda's mother is considering medical marijuana based on anecdotal evidence.

Findings:

  • Patient-reported use of marijuana in Alex suggests a perceived benefit for anxiety management.
  • The initiation of medical marijuana for Kevin indicates an exploration of alternative or adjunctive treatments for severe behavioral issues and polypharmacy.
  • The inquiry from Linda's mother reflects growing parental interest and potential demand for cannabis-based interventions in pediatric ASD populations.

Implications:

  • These cases underscore the increasing interest and exploration of medical marijuana for managing complex symptoms in individuals with ASD.
  • Further research is warranted to investigate the efficacy, safety, and optimal use of cannabinoids in pediatric and adult populations with ASD and co-occurring conditions.
  • Understanding patient and family perspectives on cannabis use is crucial for guiding clinical practice and future research in this evolving area.